Company news
Immuron Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
November 10, 2026
Immuron Engages LifeSci Capital
November 10, 2026
Emerging Growth Conference Presentation
October 28, 2026
Immuron Updates At-The-Market Funding Facility
October 26, 2026
Immuron FY27 Sales Update
October 26, 2026
CEO to present at Emerging Growth Conference
October 21, 2026
Notice of Annual General Meeting and Proxy Form
October 15, 2026
Travelan Phase 2 Study Results Published
October 12, 2026
Change in substantial holding
September 30, 2026
Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)
September 24, 2026
Appendix 4G and Corporate Governance Statement
September 24, 2026
Annual Report
September 24, 2026
Presentation to Coffee Microcaps Conference
September 21, 2026
Immuron to launch PROIBS® in the United States
September 4, 2026
PROIBS US Distribution Agreement
September 3, 2026
Immuron Reports FY26 Preliminary Results
August 28, 2026
FY26 Results Presentation
August 27, 2026
Appendix 4E Preliminary Final Report
August 27, 2026
Emerging Growth Conference Presentation
August 18, 2026
Emerging Growth Conference
August 12, 2026
IMC Rare Earths Ltd Announces Closing of $20 Million Initial Public Offering
July 30, 2026
Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar
July 20, 2026
Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year
July 16, 2026
Immuron FY26 Sales Update
July 15, 2026
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
July 6, 2026
Immuron Double Digit 3Q Sales Growth
April 17, 2026
Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference
March 5, 2026
Strategic Update and HY26 Results
February 25, 2026
Immuron Reports HY26 Results and Strategic Reset
February 25, 2026
Appendix 4D and Half Year Report
February 25, 2026
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
January 21, 2026
Immuron Reports Continued Sales Growth
January 19, 2026
Uniformed Services University to Release Topline Data
December 9, 2025
Immuron New U.S. Department of Defense Award & Clinical Trial Update
December 3, 2025
Immuron IMM-529 IND approved by FDA
November 5, 2025
IMM-529 IND approved by FDA
November 5, 2025
Immuron Announces Clinical Trial Update
October 31, 2025
Clinical Trial Update
October 30, 2025
Immuron launch PROIBS for IBS
October 23, 2025
Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.
October 21, 2025
Immuron Q1 FY26 YoY growth
October 13, 2025
Immuron Submits IMM-529 IND to FDA
October 8, 2025
Immuron Letter to Shareholders – Projects Update
October 2, 2025
FY25 Results Presentation
August 28, 2025
Appendix 4E Preliminary Final Report
August 28, 2025
Immuron partners with InvestorHub
August 26, 2025
Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream
August 20, 2025
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream
August 19, 2025
Immuron - FY25 global sales exceed projection, up 49% on prior year
July 17, 2025
FY25 global sales exceed projection, up 49% on prior year
July 16, 2025
Decks
The 5 newest of 110 decks. Every deck is listed under its year.
- Emerging Growth Conference (October 2026)
Conference · 13 slides · Oct 28, 2026
- Emerging Growth Conference 2026
Conference · 16 slides · Oct 28, 2026
- Coffee Microcaps Conference 2026
Conference · 15 slides · Sep 22, 2026
- Coffee Microcaps Conference (September 2026)
Conference · 12 slides · Sep 22, 2026
- FY2026 Earnings Presentation
Earnings · 6 slides · Aug 28, 2026